Chronic diabetic ulcers represent one of the most challenging complications in modern healthcare, affecting over 131 million people worldwide and generating approximately $755 billion in annual ...
Tissue Repair Ltd (AU:TRP) has released an update. Tissue Repair Ltd is making strides in the treatment of chronic and acute wounds with its product Glucoprime®. The company is progressing through ...
13d
SolasCure Completes Phase II Clinical Trial, Demonstrating Accelerated Healing With Aurase Wound Gel
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...
The recruitment of leukocytes is essential for the immune response, not only in initiating but also in resolving inflammation. This process is critical for maintaining homeostasis, promoting tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results